BRIEF-MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease
BRIEF-MYND Life Sciences Signs Deal To Buy Rights For Use Of Psychedelics To Treat Alzheimer's Disease
Brief-mynd生命科學公司簽署協議購買使用迷幻藥治療阿爾茨海默病的權利
Oct 27 (Reuters) - MYND Life Sciences Inc MYND.CD :
路透10月27日電-Mynd Life Science Inc MYND.CD:
* MYND LIFE SCIENCES SIGNS AGREEMENT TO ACQUIRE RIGHTS FOR THE USE OF PSYCHEDELICS TO TREAT ALZHEIMER'S DISEASE AND OTHER DEMENTIAS
*Mynd生命科學簽署協議,獲得使用迷幻劑治療阿爾茨海默病和其他痴呆症的權利
Source text for Eikon: ID:nCNW3R7hJa Further company coverage: MYND.CD
Eikon的源文本:ID:nCNW3R7hJa進一步的公司報道:MYND.CD
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com;)